Status of NF-κB and STAT3 activation in CD138+ cells from bone marrow aspirates of multiple myeloma patients
. | . | . | . | . | . | . | Nuclear* . | . | |
---|---|---|---|---|---|---|---|---|---|
Patient no. . | % plasma cells in BM differential . | MNC count, × 106 . | CD138+ MNCs, % . | Enriched CD138+, % . | Viability, % . | CD138+ count, × 106 . | NF-κB . | STAT3 . | |
1 | NA | NA | NA | NA | NA | NA | +++ | + | |
2 | 8 | 14 | NA | 93 | 90 | 1.1 | +++ | ++ | |
3 | 47 | 26 | NA | NA | 70 | NA | + | + | |
4 | 40 | 36 | NA | 98 | 95 | 5.6 | +++ | + | |
5 | 35 | 24 | NA | NA | 95 | 0.8 | ++ | +++ | |
6 | 96 | 40 | NA | 97 | 99 | 0.5 | +++ | ++ | |
7 | 45 | 21 | NA | 95 | 99 | 0.5 | +++ | + | |
8 | 18 | 12 | NA | NA | 95 | 0.2 | +++ | + | |
9 | 30 | 21 | NA | 92 | 98 | 2 | +++ | +++ | |
10 | 25 | 18 | NA | 95 | 95 | 1 | ++ | ++ | |
11 | 66 | 10 | NA | NA | 95 | 0.3 | ++ | +++ | |
12 | 63 | 38 | NA | 98 | 98 | 22 | ++ | +++ | |
13 | 14 | 6.6 | NA | 80 | 98 | 1 | +++ | +++ | |
14 | 44 | 9 | 3.59 | 60 | 98 | 0.6 | +++ | +++ | |
15 | 50 | 29 | 3.64 | 52 | 60 | 1.2 | ++ | +++ | |
16 | 22 | 6 | 7.68 | 87 | 90 | 0.6 | +++ | +++ | |
17 | 3 | 18 | 5.29 | NA | 98 | 0.3 | + | − | |
18 | 22 | 21 | NA | 72 | 50 | 1.1 | +++ | +++ | |
19 | 25 | 12 | NA | 98 | 95 | 1.5 | +++ | +++ | |
20 | 49 | 17 | 24.7 | 97 | 95 | 1.7 | +++ | +++ | |
21 | 46 | 10.2 | NA | 98 | 98 | 1.2 | +++ | +++ | |
22 | 14 | 5.4 | NA | 85 | 98 | 1.2 | + | ++ |
. | . | . | . | . | . | . | Nuclear* . | . | |
---|---|---|---|---|---|---|---|---|---|
Patient no. . | % plasma cells in BM differential . | MNC count, × 106 . | CD138+ MNCs, % . | Enriched CD138+, % . | Viability, % . | CD138+ count, × 106 . | NF-κB . | STAT3 . | |
1 | NA | NA | NA | NA | NA | NA | +++ | + | |
2 | 8 | 14 | NA | 93 | 90 | 1.1 | +++ | ++ | |
3 | 47 | 26 | NA | NA | 70 | NA | + | + | |
4 | 40 | 36 | NA | 98 | 95 | 5.6 | +++ | + | |
5 | 35 | 24 | NA | NA | 95 | 0.8 | ++ | +++ | |
6 | 96 | 40 | NA | 97 | 99 | 0.5 | +++ | ++ | |
7 | 45 | 21 | NA | 95 | 99 | 0.5 | +++ | + | |
8 | 18 | 12 | NA | NA | 95 | 0.2 | +++ | + | |
9 | 30 | 21 | NA | 92 | 98 | 2 | +++ | +++ | |
10 | 25 | 18 | NA | 95 | 95 | 1 | ++ | ++ | |
11 | 66 | 10 | NA | NA | 95 | 0.3 | ++ | +++ | |
12 | 63 | 38 | NA | 98 | 98 | 22 | ++ | +++ | |
13 | 14 | 6.6 | NA | 80 | 98 | 1 | +++ | +++ | |
14 | 44 | 9 | 3.59 | 60 | 98 | 0.6 | +++ | +++ | |
15 | 50 | 29 | 3.64 | 52 | 60 | 1.2 | ++ | +++ | |
16 | 22 | 6 | 7.68 | 87 | 90 | 0.6 | +++ | +++ | |
17 | 3 | 18 | 5.29 | NA | 98 | 0.3 | + | − | |
18 | 22 | 21 | NA | 72 | 50 | 1.1 | +++ | +++ | |
19 | 25 | 12 | NA | 98 | 95 | 1.5 | +++ | +++ | |
20 | 49 | 17 | 24.7 | 97 | 95 | 1.7 | +++ | +++ | |
21 | 46 | 10.2 | NA | 98 | 98 | 1.2 | +++ | +++ | |
22 | 14 | 5.4 | NA | 85 | 98 | 1.2 | + | ++ |
A total of 2 to 10 mL bone marrow was aspirated from the upper iliac crest or sternum and was layered over Ficoll-Paque to isolate MNCs. The cell suspension was then incubated with anti-CD138 microbeads. The cell suspension was centrifuged, and the cell pellet was loaded onto the magnetic column of the AutoMACS system. Anti-CD138+ cells were isolated by positive selection. The purity of the isolated CD138+ plasma cell population was determined by FACS analysis using anti-CD 138–PE antibody. NF-κB and STAT3 activation status was determined by fixing these cells on slides by cytospin followed by immunocytochemistry for NF-κB (p65) and STAT3 as described in “Patients, materials, and methods.”
MNC indicates mononuclear cells; STAT3, signal transducer and activator of transcription 3; NA, not available.
Grading: — indicates 0% cells with nuclear positivity; +, less than 10% cells with nuclear positivity; ++, 10% to 50% cells with nuclear positivity; +++, more than 51% cells with nuclear positivity.